See the full event guide to examine the technical and strategical developments in the discovery, validation and clinical progression of single agent and combination therapies shaking-up the precision oncology landscape. Along with the development of next generation inhibitors, explore the development of novel RAS-targeting PROTACs, molecular glues, cell therapies and vaccines boasting improved depth and durability of response as they seek for best-in-class.